J&J Medical Connect
UPTRAVI®

(selexipag)

This information is intended for US patients and caregivers to access current scientific information about J&J Innovative Medicine products. It is prepared by Medical Information and is not intended to promote the use of our products, nor to provide medical advice.

Does UPTRAVI for Injection Contain Preservatives?

Last Updated: 09/04/2024

IMPORTANT INFORMATION ABOUT UPTRAVI

  • Before you take UPTRAVI, tell your healthcare provider if you have narrowing of the pulmonary veins, a condition called pulmonary veno-occlusive disease.1

summary

  • UPTRAVI for injection does not contain preservatives.2

What are the ingredients in UPTRAVI for injection?

  • Active ingredient: selexipag1
  • Inactive ingredients: glycine, phosphoric acid, polysorbate 20, and sodium hydroxide1

additional information

This information is provided ONLY in response to your request and is not intended as medical advice, to promote the use of our product, or suggest using it in any manner other than as described in the PRESCRIBING INFORMATION. All decisions regarding your medical treatment should be made with your healthcare professional(s). Please contact your healthcare professional(s) to discuss the information in this response.

Please refer to the attached full PRESCRIBING INFORMATION and the PATIENT INFORMATION for UPTRAVI.1

 

References

1 UPTRAVI (selexipag) [Prescribing Information]. Titusville, NJ: Actelion Pharmaceuticals US, Inc, a Janssen Pharmaceutical Company. https://www.janssenlabels.com/package-insert/product-monograph/prescribing-information/UPTRAVI-pi.pdf
2 Data on File. UPTRAVI (Selexipag)- CMC Drug Registration. 2022.